Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Dyane Bailey"'
Autor:
Matthew V. Lorenzi, Raluca I. Verona, Kwok-Kin Wong, Christopher Moy, Pasi A. Janne, Kathryn Packman, Paul T. Kirschmeier, Mark A. Bittinger, Sylvie Laquerre, Catherine Sanders, Julie A. Rytlewski, Andrew H. Beck, Aditya Khosla, Jessie M. English, Catherine Ferrante, Elena Ivanova, Samuel N. Regan, Dyane Bailey, Martha R. Gowaski, Kristin DePeaux, Abha Dhaneshwar, Jeffrey Liu, Dennis M. Bonal, Wei Huang, Enrique Zudaire, Sima J. Zacharek, Mari Kuraguchi, Sangeetha Palakurthi
Supplemental figure legends 1-8, Supplementary tables 1-5, and Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::081db4e460edcdbbb5c8116b2f80a570
https://doi.org/10.1158/2326-6066.22543410
https://doi.org/10.1158/2326-6066.22543410
Autor:
Matthew V. Lorenzi, Raluca I. Verona, Kwok-Kin Wong, Christopher Moy, Pasi A. Janne, Kathryn Packman, Paul T. Kirschmeier, Mark A. Bittinger, Sylvie Laquerre, Catherine Sanders, Julie A. Rytlewski, Andrew H. Beck, Aditya Khosla, Jessie M. English, Catherine Ferrante, Elena Ivanova, Samuel N. Regan, Dyane Bailey, Martha R. Gowaski, Kristin DePeaux, Abha Dhaneshwar, Jeffrey Liu, Dennis M. Bonal, Wei Huang, Enrique Zudaire, Sima J. Zacharek, Mari Kuraguchi, Sangeetha Palakurthi
The success of targeted or immune therapies is often hampered by the emergence of resistance and/or clinical benefit in only a subset of patients. We hypothesized that combining targeted therapy with immune modulation would show enhanced antitumor re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ef82160a04751b2f6d5b28b394c18e
https://doi.org/10.1158/2326-6066.c.6550248
https://doi.org/10.1158/2326-6066.c.6550248
Autor:
Matthew V. Lorenzi, Raluca I. Verona, Kwok-Kin Wong, Christopher Moy, Pasi A. Janne, Kathryn Packman, Paul T. Kirschmeier, Mark A. Bittinger, Sylvie Laquerre, Catherine Sanders, Julie A. Rytlewski, Andrew H. Beck, Aditya Khosla, Jessie M. English, Catherine Ferrante, Elena Ivanova, Samuel N. Regan, Dyane Bailey, Martha R. Gowaski, Kristin DePeaux, Abha Dhaneshwar, Jeffrey Liu, Dennis M. Bonal, Wei Huang, Enrique Zudaire, Sima J. Zacharek, Mari Kuraguchi, Sangeetha Palakurthi
Supplemental Figures 1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a9d829db39fa7ca6cf8c4ce7a4a356
https://doi.org/10.1158/2326-6066.22543413
https://doi.org/10.1158/2326-6066.22543413
Autor:
Nadia Luheshi, Joshua P. Frederick, Ronald Herbst, Robert W. Wilkinson, Maja Sedic, Chris Morehouse, Han Si, Jean-Martin Lapointe, Philip Martin, Chris Bagnall, Michal Sulikowski, Steve Novick, David A. Leinster, Gordon Moody, Darren Potz, Katharina Deschler, Grace Adjei, Kathy Mulgrew, Eleanor Clancy-Thompson, James Moynihan, Kristen Arnold, Amanda Watkins, Sushma Gurumurthy, Ankita Mishra, Fabien Garcon, Shannon Burke, Russell Karp, Faith Musenge, Ameya Apte, John Zielinski, Dyane Bailey, Susannah L. Hewitt
Supplementary Figures S1-S11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447a2faa43430fbac4574cf80676b109
https://doi.org/10.1158/1078-0432.22477526
https://doi.org/10.1158/1078-0432.22477526
Autor:
Nadia Luheshi, Joshua P. Frederick, Ronald Herbst, Robert W. Wilkinson, Maja Sedic, Chris Morehouse, Han Si, Jean-Martin Lapointe, Philip Martin, Chris Bagnall, Michal Sulikowski, Steve Novick, David A. Leinster, Gordon Moody, Darren Potz, Katharina Deschler, Grace Adjei, Kathy Mulgrew, Eleanor Clancy-Thompson, James Moynihan, Kristen Arnold, Amanda Watkins, Sushma Gurumurthy, Ankita Mishra, Fabien Garcon, Shannon Burke, Russell Karp, Faith Musenge, Ameya Apte, John Zielinski, Dyane Bailey, Susannah L. Hewitt
Purpose:While immune checkpoint inhibitors such as anti–PD-L1 are rapidly becoming the standard of care in the treatment of many cancers, only a subset of treated patients have long-term responses. IL12 promotes antitumor immunity in mouse models;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b977133483ab014e3abfe875a2074603
https://doi.org/10.1158/1078-0432.c.6529685
https://doi.org/10.1158/1078-0432.c.6529685
Autor:
Nadia Luheshi, Joshua P. Frederick, Ronald Herbst, Robert W. Wilkinson, Maja Sedic, Chris Morehouse, Han Si, Jean-Martin Lapointe, Philip Martin, Chris Bagnall, Michal Sulikowski, Steve Novick, David A. Leinster, Gordon Moody, Darren Potz, Katharina Deschler, Grace Adjei, Kathy Mulgrew, Eleanor Clancy-Thompson, James Moynihan, Kristen Arnold, Amanda Watkins, Sushma Gurumurthy, Ankita Mishra, Fabien Garcon, Shannon Burke, Russell Karp, Faith Musenge, Ameya Apte, John Zielinski, Dyane Bailey, Susannah L. Hewitt
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e329b32ceccaccb01d825f32846ab6
https://doi.org/10.1158/1078-0432.22477523
https://doi.org/10.1158/1078-0432.22477523
Autor:
Kristen Arnold, Chris Morehouse, Eleanor Clancy-Thompson, Katharina Deschler, Susannah Hewitt, Russell Karp, Ameya Apte, Chris Bagnall, Faith Musenge, Darren Potz, David A. Leinster, Kathy Mulgrew, Ankita Mishra, Gordon Moody, Maja Sedic, Joshua Frederick, John Zielinski, Fabien Garcon, Sushma Gurumurthy, Nadia Luheshi, Michal Sulikowski, Steve Novick, Han Si, Philip Martin, Grace Adjei, James Moynihan, Jean-Martin Lapointe, Amanda Watkins, Shannon Burke, Ronald Herbst, Dyane Bailey, Robert W. Wilkinson
Publikováno v:
Clinical Cancer Research. 26:6284-6298
Purpose: While immune checkpoint inhibitors such as anti–PD-L1 are rapidly becoming the standard of care in the treatment of many cancers, only a subset of treated patients have long-term responses. IL12 promotes antitumor immunity in mouse models;
Autor:
Paul Kirschmeier, Jeffrey Liu, Andrew H. Beck, Catherine Ferrante, Sangeetha Palakurthi, Christopher Moy, Elena Ivanova, Mark A. Bittinger, Martha R. Gowaski, Abha Dhaneshwar, Dennis M. Bonal, Mari Kuraguchi, Matthew V. Lorenzi, Kwok-Kin Wong, Kristin Depeaux, Samuel N. Regan, Jessie M. English, Catherine Sanders, Raluca I. Verona, Julie A. Rytlewski, Pasi A. Jänne, Kathryn Packman, Dyane Bailey, Enrique Zudaire, Wei Huang, Sima Zacharek, Sylvie Laquerre, Aditya Khosla
Publikováno v:
Cancer Immunology Research. 7:1457-1471
The success of targeted or immune therapies is often hampered by the emergence of resistance and/or clinical benefit in only a subset of patients. We hypothesized that combining targeted therapy with immune modulation would show enhanced antitumor re
Autor:
Ashley Davis, Kristen Arnold, Russell Karp, Maria S. Iliou, Khushbu Bhatt, John Zielinski, Joshua Frederick, Ameya Apte, Maija Garnaas, Samuel J. Farlow, Sima Zacharek, Nikhil Khatwani, Dyane Bailey, Kana Ichikawa, Ailin Bai, Faith Musenge, Susannah Hewitt, Stephen V. Su, Graham MacLean, Kristin E. Burke
Publikováno v:
Science Translational Medicine. 11
Many solid cancers contain dysfunctional immune microenvironments. Immune system modulators that initiate responses to foreign pathogens could be promising candidates for reigniting productive responses toward tumors. Interleukin-1 (IL-1) and IL-12 c
Publikováno v:
Molecular Imaging and Biology. 16:478-487
This study describes an imaging strategy based on glow stick chemistry to non-invasively image oxidative stress and reactive oxygen species (ROS) production in living animals. Upon stimulation, phagocytes produce toxic levels of ROS to kill engulfed